PETRI DISH PERSPECTIVES

Episode 79: Endeavor Health

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Endeavor Health, the Chicago-area hospital system most Illinoisans have driven past but couldn’t

Episode 78: Dr. Kristin Gleitsman on Using AI to Make Better Drug Development Decisions

Send us Fan Mail After years of building discovery engines inside diagnostics, Kristin Gleitsman has become one of the more skeptical voices in AI and biology. A Caltech

Episode 77: Revolution Medicines

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Revolution Medicines, the precision oncology company that spent over a decade trying to drug one

Episode 76: Dr. Avinash Jayaraman on Why Your Kid's Screen Time Is a Clinical Emergency

Send us Fan Mail After training as a physician, earning an MBA from Wharton, and co-founding Sonara Health, a digital health company that raised over $10 million from th

September 2026: Biotech & Pharma NEWS Roundup

Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for September 2026! This month was defined by blockbuster dealmak

Episode 75: Hengrui

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Jiangsu Hengrui Pharmaceuticals, the Chinese pharma giant that started as a state-owned generic d

Episode 74: Dr. John Murphy on Building an Audience

Send us Fan Mail After years of running a school on the rigid rhythm of bells, Dr. John Murphy walked away from K-12 education and into something he never trained for: p

Episode 73: Anew Labs

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Anew Labs, the AI drug discovery company that emerged from one of the most unexpected places in b

Episode 72: Dr. Elliot Justin on S3xual Wearable Health Tech

Send us Fan Mail After a career spent racing against the clock in emergency rooms, Dr. Elliot Justin found himself chasing a very different kind of vital sign, one most

Episode 71: Fate of Pharma M&A

Send us Fan Mail In this episode of Petri Dish Perspectives, we take a step back from individual companies to examine one of the most powerful forces shaping the pharmac

August 2026: Biotech & Pharma NEWS Roundup

Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for August 2026! This month was defined by major dealmaking, a re

Episode 70: Cellares

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Cellares, the biotech company trying to solve one of the biggest and least discussed challenges i

Episode 69: Summit Therapeutics

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the remarkable rise of Summit Therapeutics, a biotech that transformed itself from an infectious-

Episode 68: Guardant Health

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Guardant Health, one of the companies leading the shift toward blood-based cancer de

Episode 67: Epic Systems

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Epic Systems, the privately held healthcare technology company that has quietly buil

July 2026: Biotech & Pharma NEWS Roundup

Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for June 2026! This month was dominated by AI cementing itself as

Episode 66: Scribe Therapeutics

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Scribe Therapeutics, one of genome editing's most ambitious companies aiming to

Episode 65: Apogee Therapeutics

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Apogee Therapeutics, one of biotech's newest immunology companies aiming to red

Episode 64: Conception Bio

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Conception Bio, one of the most ambitious biotechnology companies working at the int

Episode 63: Enveda Biosciences

Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Enveda Biosciences, one of the most exciting AI-native biotech companies redefining